The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Vasileva A.V.

Bekhterev National Research Medical Center for Psychiatry and Neurology;
Mechnikov North-Western State Medical University

Pandemic and mental adjustment disorders. Therapy options

Authors:

Vasileva A.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(5): 146‑152

DOI: 10.17116/jnevro2020120051146

Read: 3169 times

Download PDF (RU)
Contact the author
Table of contents

PANDEMIC AND MENTAL ADJUSTMENT DISORDERS. THERAPY OPTIONS
PANDEMIC AND MENTAL ADJUSTMENT DISORDERS. THERAPY OPTIONS

To cite this article:

Vasileva AV. Pandemic and mental adjustment disorders. Therapy options. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(5):146‑152. (In Russ.)
https://doi.org/10.17116/jnevro2020120051146

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Subjective sleep quality evaluation in patients with neuromyelitis optica spectrum diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):57-61
Como­rbid anxiety diso­rders in patients with neurological pathology: current state of the problem and the role of etifoxine in treatment stra­tegy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):126-136
New oppo­rtunities for therapy of adju­stment diso­rder in combat participants: resu­lts of a study on the dome­stic drug Aviandr. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):62-69
The state of mental health of migrant workers and citi­zens of the Russian Fede­ration: A comparative analysis as illu­strated by the Moscow region. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):95-101
Depression Anxiety Stress Scale (russian language version). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):103-107
Inve­stigation of the rela­tionship of indi­vidual characteristics of the brain bioelectrical acti­vity with levels of mental stress, aggression, anxiety, and depression. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):108-117
Atopic dermatitis and skin toxic reactions: comparative characteristics, psychosomatic aspe­cts and patient mana­gement tactics. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):744-752
Influence of enzy­matic acti­vity of microbiota on hemo­dynamics, arte­rial stiffness and emotional state of patients with mild-to-moderate risk of cardiovascular complications. Russian Cardiology Bulletin. 2024;(4-2):128-136
Prediction and prevention of burnout syndrome in health care professionals in high epidemic risk settings. Russian Journal of Preventive Medi­cine. 2025;(4):51-56
Conscious seda­tion with benzodiazepines in pediatric outpatient dentistry. Russian Journal of Anesthesiology and Reanimatology. 2025;(3):55-63
Abstract:

The article considers the main triggers of adjustment and anxiety disorders in the time of pandemic that brings significant changes in all life dimensions with the high uncertainty level. The article highlights a role of coronavirus infodemic in the development of anxiety disorders. The main targets for cognitive, emotional and behavioral interventions are suggested. Recommendations for anxiety adjustment disorders psychopharmacotherapy with the use of tranquillizers as treatment of choice are given. Prevention measures for medical doctors working in conditions of pandemic are proposed.

Keywords:

anxiety
adjustment disorder
coronavirus
emotional contamination
pandemic
infodemic
cognitive-behavioral psychotherapy
tranquilizers

Authors:

Vasileva A.V.

Bekhterev National Research Medical Center for Psychiatry and Neurology;
Mechnikov North-Western State Medical University

Received:

15.04.2020

Accepted:

29.04.2020

Close metadata

References:

  1. World Health Organization. Noncommunicable diseases surveillance. Geneva: World Health Organization. https://www.who.int/ncd_surveillance/en/World Health Organization.
  2. GBD Study (2017a) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries, 1990—2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2017;(390, 10100):1211-1259.
  3. GBD Study (2017b) Global Burden of Disease Study, Global, regional, and national comparative risk assessment of 84 behavioral, environmental and occupational, and metabolic risks or clusters of risks, 1990—2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;390(10100):1345-1422.
  4. Bone A, Guthmann J, Nicolau J, Levy-Bruhl D. Population and Risk Group Uptake of H1N1 Influenza Vaccine in Mainland France 2009—2010: Results of a National Vaccination Campaign. Vaccine. 2010;28(51):8157-8161.
  5. Joffe H. Public Apprehension of Emerging Infectious Diseases: Are Changes Afoot? Public Understanding of Science. 2011;20(4):446-460.  https://doi.org/10.1177/0963662510391604
  6. Crawford R. The Boundaries of the Self and the Unhealthy Other: Reflections on Health, Culture and AIDS. Social Science & Medicine. 1994;38(10):1347-1346.
  7. Eichelberger L. SARS and New York’s Chinatown: The Politics of Risk and Blame during an Epidemic of Fear. Social Science & Medicine. 2007;65(6):1284-1295.
  8. Yang Y, Li W, Zhang L, Zhang Q, Cheung T, Ng CH. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry. 2020;7(3):228-229.  https://doi.org/10.1016/S2215-0366(20)30046-8
  9. Shigemura J, Ursano RJ, Morganstein JC, Kurosawa M, Benedek DM. Public responses to the novel 2019 coronavirus (2019-nCoV) in Japan: mental health consequences and target populations. Psychiatry Clin Neurosci. 2020;74:281-282. 
  10. Van Bortel T, Basnayake A, Wurie F, et al. Psychosocial effects of an Ebola outbreak at individual, community and international levels. Bull World Health Organ. 2016;94:210-214. 
  11. WHO Briefing note on addressing mental health and psychosocial aspects of COVID-19: https://interagencystandingcommittee.org/other/interim-briefing-note-addressing-mental-health-andpsychosocial-aspects-covid-19-outbreak
  12. Ho CS, Chee CY, Ho RC. Mental health strategies to combat the psychological impact of COVID-19 beyond paranoia and panic. Ann Acad Med Singapore. 2020;49(1):1-3. 
  13. Lima CKT, Carvalho PMM, Lima IAAS, Nunes JVAO, Saraiva JS, de Souza RI, da Silva CGL, Neto MLR. The emotional impact of Coronavirus 2019-nCoV (new coronavirus disease). Psychiatry Res. 2020;287. [Epub ahead of print].
  14. Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, Ho RC. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health. 2020;17(5):E1729.
  15. Maunder RG. Was SARS a mental health catastrophe? Gen Hosp Psychiatry. 2009;31(2009):316-317. 
  16. WHO director general’s opening remarks at the media briefing on covid-19.  https://www.who.int/ru/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
  17. Li Z, Ge J, Yang M, Feng J, Qiao M, Jiang R, Bi J, Zhan G, Xu X, Wang L, Zhou Q, Zhou C, Pan Y, Liu S, Zhang H, Yang J, Zhu B, Hu Y, Hashimoto K, Jia Y, Wang H, Wang R, Liu C, Yang C. Vicarious traumatization in the general public, members, and non-members of medical teams aiding in COVID-19 control. Brain Behav Immun. 2020;10(20) https://doi.org/10.1016/j.bbi.2020.03.007
  18. Dong L, Bouey J. Public mental health crisis during COVID-19 pandemic, China. Emerg Infect Dis. 2020;23(26). https://doi.org/10.3201/eid2607.200407.
  19. Bao Y, Sun Y, Meng S, Shi J, Lu L. 2019-nCoV epidemic: address mental health care to empower society. Lancet. 2020;22(395):37-38. 
  20. Kun P, Han S, Chen X, Yao L. Prevalence and risk factors for posttraumatic stress disorder: a cross-sectional study among survivors of the Wenchuan 2008 earthquake in China. Depress Anxiety. 2009;26:1134-1140.
  21. Psychiatria. Nationalnoe rukovodsctvo. Gl. red. Alexandrovsky YA, Neznanov NG. M.: GEOTAR-Media; 2018. (In Russ.).
  22. Levis-Strauss K. Strukturnaya antropologia. Translated from French. M.: Exmo-Press; 2001. (In Russ.).
  23. Ostrovsky AB. Paradigma mifologicheskogo mishlenia: ocherk vklada Clauda Levis-Straussa. SPb.: 2004. (In Russ.).
  24. McEwen BS, Sapolsky RM. Stress and cognitive function. Current Opinion in Neurobiology. 1995;(5, 2):205-216.  https://doi.org/10.1016/0959-4388(95)80028-X
  25. Burghy Ca, Stodola DE, Ruttle PL, Molloy EK, Armstrong JM, Oler Ja, Birn RM. Developmental pathways to amygdala-prefrontal function and internalizing symptoms in adolescence. Nature Neuroscience. 2012;15(12):1736-1741. https://doi.org/10.1038/nn.3257
  26. Callaghan BL, Tottenham N. The Stress Acceleration Hypothesis: Effects of early-life adversity on emotion circuits and behavior. Current Opinion in Behavioral Sciences. 2016;7:76-81.  https://doi.org/10.1016/j.cobeha.2015.11.018
  27. Dannlowski U, Kugel H, Huber F, Stuhrmann A, Redlich R, Grotegerd D, Suslow T. Childhood maltreatment is associated with an automatic negative emotion processing bias in the amygdala. Human Brain Mapping. 2013;34(11):2899-2909. https://doi.org/10.1002/hbm.22112
  28. Etkin A, Klemenhagen KC, Dudman JT, Rogan MT, Hen R, Kandel ER, Hirsch J. Individual differences in trait anxiety predict the response of the basolateral amygdala to unconsciously processed fearful faces. Neuron. 2004;44(6):1043-1055. https://doi.org/10.1016/j.neuron.2004.12.006
  29. Evans GW, Swain JE, King AP, Wang X, Javanbakht A, Ho SS, Liberzon I. Childhood Cumulative Risk Exposure and Adult Amygdala Volume and Function. Journal of Neuroscience Research. 2016;94(6):535-543.  https://doi.org/10.1002/jnr.23681
  30. Gabard-Durnam LJ, Flannery J, Goff B, Gee DG, Humphreys KL, Telzer E, Tottenham N. The development of human amygdala functional connectivity at rest from 4 to 23 years: a cross-sectional study. NeuroImage. 2014;95:193-207.  https://doi.org/10.1016/j.neuroimage.2014.03.038
  31. Kotsubinsky AP, Skorik AI, Sheinina NS, Axenova IO, Aristova TA, Penchul NA, Butoma BG. Psychiatric mythology and alliance problems. Socialnaya i Klinicheskaya Psychiatria. 2009;3:31-36. (In Russ.).
  32. Neznanov NG, Kotsyubinsky AP, Kotsyubinsky DA. Crisis of natural-scientific and human approaches in psychiatry. Obozrenie psikhiatrii i meditsinskoi psikhologii im. V.M. Bekhtereva. 2019;1:8-15. (In Russ.). https://doi.org/10.31363/2313-7053-2019-1-8-15
  33. Azim D, Kumar S, Nasim S, Arif T, Nanjiani D. COVID-19 as a psychological contagion: a new Pandora’s box to close? Infection Control &Hospital Epidemiology. 2020;1-2. Accessed April 2020  https://doi.org/10.1017/ice.2020.127
  34. Kramer ADI. The spread of emotion via Facebook. Proc CHI (Association for Computing Machinery, New York). 2012;767-770.  https://doi.org/10.1145/2207676.2207787
  35. Kramer ADI, Guillory JE, Hancock JT. Experimental evidence of massive-scale emotional contagion through social networks. PNAS Proceedings of the National Academy of Sciences of the United States of America. 2014;111(24):8788-8790. https://doi.org/10.1073/pnas.1320040111
  36. Bart R. Mifologii. Translated form French. M.: Izd-vo im. Sabashnikovih; 2004. (In Russ.).
  37. ВОЗ Рекомендации по поддержанию психического здоровья и психосоциального состояния во время вспышки COVID-19, 2020.
  38. Wang Y, McKee M, Torbica A, Stuckler D. Systematic literature review on the spread of health-related misinformation on social media. Soc Sci Med. 2019;240:112552.
  39. Kumar KPK, Geethakumari G. Detecting misinformation in online social networks using cognitive psychology. Hum Cent Comput Inf Sci. 2014;4:14.  https://doi.org/10.1186/s13673-014-0014-x
  40. Moeller SD. Compassion Fatigue: How the Media Sell Disease, Famine, War and Death. New York: Routledge; 1999.
  41. Gilman SL. Disease and Representation: Images of Illness from Madness to AIDS. Ithaca: Cornell University Press; 1988.
  42. Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395:912-920.  https://doi.org/10.1016/S0140-6736(20)30460-8
  43. Bekhterev VM. Vnushenie I ego rol v obschestvennoi gizni. SPb.: Piter; 2001. (In Russ.).
  44. Asmundson GJG, Taylor S. How health anxiety influences responses to viral outbreaks like COVID-19: what all decision-makers, health authorities, and health care professionals need to know. J Anxiety Disord. 2020;71:102211. [Epub ahead of print].
  45. Banerjee D. The COVID-19 outbreak: crucial role the psychiatrists can play. Asian J Psychiatr. 2020;51. [Epub ahead of print].
  46. Bao Y, Sun Y, Meng S, Shi J, Lu L. 2019-nCoV epidemic: address mental health care to empower society. Lancet. 2020;22(395):37-38. 
  47. Bish A, Michie S. Demographic and attitudinal determinants of protective behaviours during a pandemic: A review. British Journal of Health Psychology. 2010;15:787-824. 
  48. Bish A, Yardley L, Nicoll A. Factors associated with uptake of vaccination against pandemic influenza: A systematic review. Vaccine. 2011;29(38):6472-6484.
  49. Tashlykov VA. Vnutrennyaya kartina bolezni pri nevrozah i ee znachenie dlya therapii i prognoza. In: Neznanov NG. eds. Bolezn i zdorovie, psychoterapiya i soperegeivanie. SPb.: OOO Izdatelskii dom «Alfa-Press»; 2019. (In Russ.).
  50. Mo PK, Lau JT. Illness representation on H1N1 influenza and preventive behaviors in Hong Kong general population. J Health Psychol. 2015;20:1523-1533.
  51. Karademas E, Bati A, Vassiliki K. The association between pandemic influenza A (H1N1) public perceptions and reactions: A prospective study. Journal of Health Psychology. 2013;18:419-428. 
  52. Asmundson GJG, Taylor S. Coronaphobia: fear and the 2019-nCoV outbreak. J Anxiety Disord. 2020;70. [Epub ahead of print].
  53. Karavaeva TA, Vasileva AV, Poltorak SV, Grebenukov SV, Kolesova YP. Panic disorder criteria and diagnostic algorithm. Obozrenie psikhiatrii i meditsinskoi psikhologii im. V.M. Bekhtereva. 2015;2:3-9. (In Russ.).
  54. Watanabe N, Churchill R, Furukawa TA. Combined psychotherapy plus benzodiazepines for panic disorder. Cochrane Database of Systematic Reviews. 2009;1:CD005335. https://doi.org/10.1002/14651858.CD005335
  55. Karavaeva TA, Vasileva AV, Poltorak SV, Mizinova EB, Belan RM. Anxiety-phobic disorders criteria and diagnostic algorithm. Obozrenie psikhiatrii i meditsinskoi psikhologii im. V.M. Bekhtereva. 2015;4:117-122. (In Russ.).
  56. Karavaeva TA, Vasileva AV, Poltorak SV, Chekhlaty EI, Lukoshkina EP. Generalized anxiety disorder criteria and diagnostic algorithm. Obozrenie psikhiatrii i meditsinskoi psikhologii im. V.M. Bekhtereva. 2015;3:124-130. (In Russ.).
  57. Sivolap YP. Panic disorder clinical phenomena and therapy options. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2017;117:4:112-116. (In Russ.).
  58. Gorbunova AA, Koluckaya EB. Panic disorder and affective pathology (comorbidity aspects). Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2014;14:10:9-13. (In Russ.).
  59. Eaton WW, Bienvenu OJ, Miloyan B. Specific phobias. Lancet Psychiatry. 2018;5(8):678-686.  https://doi.org/10.1016/S2215-0366(18)30169-X
  60. Dutheil F, Mondillon L, Navel. V. PTSD as the second tsunami of the SARS-Cov2 pandemic. Psychological Medicine. 2020;1:1-6.  https://doi.org/10.1017/S0033291720001336
  61. Cuijpers P, Gentili C, Banos RM, et al. Relative effects of cognitive and behavioral therapies on generalized anxiety disorder, social anxiety disorder and panic disorder: A meta-analysis. J Anxiety Disord. 2016;43:79-89.  https://doi.org/10.1016/j.janxdis.2016.09.003
  62. Olthuis JV, Watt MC, Bailey K, et al. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults. Cochrane Database Syst Rev. 2016;3(5):CD011565. https://doi.org/10.1002/14651858.CD011565
  63. Garcia R. Neurobiology of fear and specific phobias. Learn Mem. 2017;24(9):462-471.  https://doi.org/10.1101/lm.044115.116
  64. LeDoux JE, Pine DS. Using Neuroscience to Help Understand Fear and Anxiety: A Two-System Framework. Am J Psychiatry. 2016;173(11):1083-1093. https://doi.org/10.1176/appi.ajp.2016.16030353
  65. Alexandrovsky YA, Chekhonin VP. Clinical-immunological research in borderline mental disorders. Vestnik rossiiskoi akademii medicinskih nauk. 1999;7:12-15. (In Russ.).
  66. Chekhonin VP, Gurina OI, Alexandorvsky YA, Novikov DD, Moroz IN. Cell and humoral immunity characteristics in different asthenia forms patients. Immunology. 2003;4:238-242. (In Russ.).
  67. Samotrueva MA, Yasenyavskaya AL, Cibizova AA, Bashkina OA, Galimzyanov HM, Turenkov IN. Neuroimmunoengdocrinology: molecular mechanisms modern understanding. Immunology. 2017;38(1):49-59. (In Russ.).
  68. Mayorova MA, Petrova NN, Stroev UI, Churilov LP, Shoenfeld Y. Interrelation of auto-immune process, endocrine disorders and depression. Obozrenie psikhiatrii i meditsinskoi psikhologii im. V.M. Bekhtereva. 2020;1:8-19. (In Russ.). https://doi.org/10.31363/2313-7053-2020-1-8-19
  69. Besedovsky HO, Del Rey A, Sorkin E. Neuroendocrine immunoregulation. Immunoregulation. Ed N Fabris, et al. New York. 1983.
  70. Ellul P, Mariotti-Ferrandiz E, Leboyer M, Klatzmann D. Regulatory T-cells as supporters of psychoimmune resilience: toward immunotherapy of major depressive disorder. Front Neurol. 2018. https://doi.org/10.3389/fneur.2018.00167
  71. Eusden J, Danese A, Lewis CM, Maughan B. A bidirectional relationship between depression and the autoimmune disorders — New perspectives from the National Child Development Study. PLoS One. 2017;12(3):e0173015. https://doi.org/10.1371/journal.pone.0173015
  72. Himmerich H, Patsalos O, Lichtblau N, Ibrahim MAA, Dalton B. Cytokine research in depression: principles, challenges and open questions. Front Psychiatry. 2019;10:30.  https://doi.org/10.3389/fpsyt.2019.00030
  73. Sharif K, Watad A, Coplan L, Lichtbroun B, Krosser A, Lichtbroun M, Bragazzi NL, Amital H, Afek A, Shoenfeld Y. The role of stress in the mosaic of autoimmunity: an overlooked association. Autoimmun Rev. 2018;17(10):967-983. 
  74. Quagliato LA, Nardi AE. Cytokine alterations in panic disorder: A systematic review. J Affect Disord. 2018;1(228):91-96.  https://doi.org/10.1016/j.jad.2017.11.094
  75. Zorn JV, Schür RR, Boks MP. Cortisol stress reactivity across psychiatric disorders: A systematic review and meta-analysis. Psychoneuroendocrinology. 2017;77:25-36.  https://doi.org/10.1016/j.psyneuen.2016.11.036
  76. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan. China Clin Infect Dis. 2020;10.1093/cid/ciaa248 
  77. Conti P, Ronconi G, Caraffa A, Gallenga CE, Ross R, Frydas I, Kritas SK. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by COVID-19: anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020;34. [Epub ahead of print].
  78. Kim HC, Yoo SY, Lee BH, Lee SH, Shin HS. Psychiatric findings in suspected and confirmed Middle East Respiratory Syndrome patients quarantined in hospital: a retrospective chart analysis. Psychiatry Investig. 2018;15:355-360.  https://doi.org/10.30773/pi.2017.10.25.1
  79. Kim Sung, Su Kuan-Pin. Using psychoneuroimmunity against COVID-19. Brain, Behavior, and Immunity. 2020;3. Accessed on 17 April, 2020. https://doi.org/10.1016/j.bbi.2020.03.025
  80. WHO Coping with stress during the 2019-nCoV outbreak. Accessed on 17 April, 2020. https://www.who.int/docs/default-source/coronaviruse/coping-with-stress.pdf
  81. EPA recommendations on COVID-19. Accessed on 17 April, 2020. https://www.europsy.net/covid-19-resource-centre/
  82. National Health Commission of China. A notice on the issuance of guidelines for emergency psychological crisis intervention in pneumonia for novel coronavirus infections. Accessed 17 April, 2020. In Chin. https://www.nhc.gov.cn/xcs/zhengcwj/20 2001/6adc08b966594253b2b791be5c3b9467.shtml
  83. Roberts AR. Crisis intervention handbook: assessment, treatment, and research, 3rd edn. Oxford: Oxford University Press; 2005.
  84. Leahey R. Svoboda ot trevogi. SPb.: Piter; 2017. (In Russ.).
  85. Klinicheskaya psychotherapiya v obschei vrachebnoi praktike. Pod. red. Neznanov NG, Karvassarsky BD. SPb.: Piter; 2008. (In Russ.).
  86. Duan Li, Zhu Gang. Psychological interventions for people affected by the COVID-19 epidemic. The Lancet Psychiatry. 2020;7.  https://doi.org/10.1016/S2215-0366(20)30073-0
  87. Troitsky MS., Tokarev AR., Panshina MV. Opportunities of non-profit-pharmacological and drug therapy of anxiety disorders (review references). Bulletin of new medical technologies. 2018;25:1:61-70. 
  88. Walz LC, Nauta MH, Aan Het Rot M. Experience sampling and ecological momentary assessment for studying the daily lives of patients with anxiety disorders: a systematic review. J Anxiety Disord. 2014;28(8):925-937.  https://doi.org/10.1016/j.janxdis.2014.09.022
  89. Keng S, Smoski M, Robins C. Effects of mindfulness on psychological health: A review of empirical studies. Clinical Psychology Review. 2011;31:1041-1056.
  90. Мартюшев-Поклад А.В., Воронина Т.А. Стресслимитирующие системы и нейрональная пластичность в патогенезе психических и неврологических расстройств. Обзоры по клинической фармакологии и лекарственной терапии. 2003;4(2):15-25. 
  91. Rationalnaya pharmacotherapia v psychiatricheskoi praktike. Pod. red. Alexandrovsky YA, Neznanov NG. M.: GEOTAR-Media; 2014. (In Russ.). Martyushev-Poklad A.V., Voronina T. A. Stress-Limiting systems and neuronal plasticity in the pathogenesis of mental and neurological disorders. Reviews of clinical pharmacology and medicinestem cell therapy. 2003;4(2):15-25
  92. Bandelow Borwin, Sher Leo, Bunevicius Robertas, Hollander Eric, Kasper Siegfried, Zohar, Joseph Möller, Hans-Jürgen. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. International journal of psychiatry in clinical practice. 2012;16:77-84.  https://doi.org/10.3109/13651501.2012.667114
  93. Psychiatria. Nationalnoe rukovodsctvo. Gl. Red. Alexandrovsky YA, Neznanov NG. M.: GEOTAR-Media; 2018. (In Russ.).
  94. Vasileva AV, Karavaeva TA, Poltorak SV, Kolesova YP. Neurotic level anxiety disorders (panic, generalized anxiety and anxiety-phobic disorders) pschopharmacoceutical treatment principles and algorithms. Obozrenie psikhiatrii i meditsinskoi psikhologii im. V.M. Bekhtereva.2016;1:3-9. (In Russ.).
  95. Ronai Sh, Oros F, Bolla K. the use of grandaxine in out-patient setting. Venger Pharmacother. 1975;4-10. (In Russ.).
  96. Alexandorvsky YA, Avedisova AS, Pavlova MS. The vegetotropic effect of grandaxine in primary care neurotic disorders treatment. Therapevticheskii arkhiv. 1998;10:76-85. (In Russ.).
  97. Vein AM, Artemenko AP, Oknin VY, Pomorcev IV. Grandaxin efficacy in the psychovegetative disorders correction. Klinicheskaya medicina. 1999;6:41-45. (In Russ.).
  98. Vasileva AV, Karavaeva TA, Semiglazova TY. Specific of the psychopharmacotherapy in oncology patients with anxiety disorders. Voprosi oncologii. 2018;64(5):567-661. (In Russ.).
  99. Poplavskaya O. V., Tsybulya, Y. V. Modern approaches to the use of grandaxinum (tofisopam) in therapy of asthenic States. Lekar-official Gazette. 2017;1(65):1. 
  100. van Gelder N, Peterman A, Potts A, et al. COVID-19: Reducing the risk of infection might increase the risk of intimate partner violence [published online ahead of print, 2020 Apr 11. EClinical Medicine. 2020;100348. https://doi.org/10.1016/j.eclinm.2020.100348
  101. Zhu Z, Xu S, Wang H, Liu Z, Wu J, Li G, Miao J, Zhang C, Yang Y, Sun W, Zhu S, Fan Y, Hu J, Liu J, Wang W. COVID-19 in Wuhan: Immediate Psychological Impact on 5062. Health Workers. Cold Spring Harbor Laboratory Press, Yale. 2020. https://doi.org/10.1101/2020.02.20.20025338
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.